1. Home
  2. INUV vs ITRM Comparison

INUV vs ITRM Comparison

Compare INUV & ITRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Inuvo Inc.

INUV

Inuvo Inc.

HOLD

Current Price

$1.89

Market Cap

28.3M

ML Signal

HOLD

Logo Iterum Therapeutics plc

ITRM

Iterum Therapeutics plc

HOLD

Current Price

$0.03

Market Cap

24.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INUV
ITRM
Founded
N/A
2015
Country
United States
Ireland
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.3M
24.3M
IPO Year
1996
2018

Fundamental Metrics

Financial Performance
Metric
INUV
ITRM
Price
$1.89
$0.03
Analyst Decision
Strong Buy
Buy
Analyst Count
4
2
Target Price
$11.00
$9.00
AVG Volume (30 Days)
202.8K
30.9M
Earning Date
05-07-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
50.00
57.43
EPS
N/A
N/A
Revenue
$86,209,305.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$12.89
$947.65
P/E Ratio
N/A
N/A
Revenue Growth
2.88
N/A
52 Week Low
$0.36
$0.03
52 Week High
$6.27
$1.16

Technical Indicators

Market Signals
Indicator
INUV
ITRM
Relative Strength Index (RSI) 42.59 26.10
Support Level $1.82 N/A
Resistance Level $1.99 $0.39
Average True Range (ATR) 0.12 0.02
MACD 0.00 -0.01
Stochastic Oscillator 27.03 3.34

Price Performance

Historical Comparison
INUV
ITRM

About INUV Inuvo Inc.

Inuvo Inc is an advertising technology and services company that has developed and commercialized large language generative artificial intelligence (AI) for modeling media audiences. Its products and services include ValidClick and IntentKey. The company's platforms identify and message online audiences for any product or service across devices, channels, and formats, including video, mobile, connected TV, display, social, and native. It has clients from various industries that include retail, automotive, insurance, health care, technology, telecommunications and finance. Inuvo's revenue is derived from the placement of digital advertising throughout devices, websites, applications and browsers across social, search and programmatic advertising channels.

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

Share on Social Networks: